Olympus Capital Asia Divests Major Stake in Aster DM Healthcare for Rs 1,530 Crore

Hong Kong-based Olympus Capital Asia sold a 9% stake in Aster DM Healthcare for Rs 1,530 crore via open market transactions. The shares were sold on BSE at Rs 340-340.13 each. This divestment reduced Olympus Capital's stake to 1.1%. Franklin Templeton Mutual Fund, Morgan Stanley Asia, and the Singapore government acquired 1.24 crore shares.

Hong Kong-based Olympus Capital Asia made a significant move on Friday, divesting a 9 per cent stake in the notable hospital chain, Aster DM Healthcare, through open market transactions. The substantial transaction drew Rs 1,530 crore.

The investment firm executed the sell-off via its arm, Olympus Capital Asia Investments, focusing on the BSE platform. Bulk deal data revealed that Olympus Capital Asia Investments offloaded 4.50 crore shares in Aster DM Healthcare across two tranches.

Shares were sold within a narrow price band of Rs 340-340.13 apiece, bringing the total transaction value to an impressive Rs 1,530.08 crore. Consequently, Olympus Capital's stake in Aster DM Healthcare has been trimmed to 1.1 per cent from a previous 10.1 per cent. Prominent buyers include Franklin Templeton Mutual Fund, Singapore government, and Morgan Stanley Asia, who together snapped up 1.24 crore shares at an average price of Rs 340, totaling Rs 423.31 crore. The other buyers remain unidentified. The market reacted positively, with Aster DM Healthcare shares closing up 2.78 per cent at Rs 366.25 on the BSE.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)